daratumumab,talquetamab,teclistamab
janssen,genmab
['redirectt-1', 'janssen']
our #bloodcancer research reinforces our commitment to developing additional, customized options to help physicians tailor treatment regimens for their patients. learn more about the first data from our phase 1b redirectt-1 study at #asco23: 
At Janssen, we never stop working toward a future where disease is a thing of the past. Channel run by Janssen Global Services LLC, NJ, USA.